investor.catalent.comCatalent, Inc. - Investor Relations

Investor Home Center Company News Financial News Events & Presentations Events Calendar Presentations Stock Info Stock Quote Stock Chart Historical Stock Quote Investment Calculator Analyst Coverage Financials Annual Reports SEC Filings Governance Governance Documents Corporate Responsibility Committee Composition Resources Investor FAQs Information Request Form Investor Email Alerts RSS FeedsRegional SitesChina Japan Latin America Spanish PortugueseSearch for Submit Contact Us Oral DoseDevelopment & BioavailabilityPreclinical Development Formulation Bioavailability Enhancement Integrated Development Solutions OptiForm® Solution Suite Catalent Xpress Pharmaceutics™ Dose Form DesignOptiDose® Design Solution Tablets & Capsules Orally Disintegrating Tablets Softgel Technology Stick Pack Oral TechnologiesBioavailability Enhancement Modified Release Formulations Orally Disintegrating Tablets Abuse Deterrent Oral Macromolecule Delivery Softgel TechnologiesRP Scherer Softgel Technology Plant Based Softgel Technology Oral Macromolecule Delivery Abuse Deterrent Technology Smaller Easy to Swallow Softgels Oral ManufacturingCommercial Manufacturing Scale-Up & Product Launch Technology Transfers OneXpress™ Solution Oral Dose Packaging Oral Dose Analytical SolutionsSolid State Screening Methods Development & Validation Stability Testing & Storage Highly Potent Active Pharmaceutical Ingredients BiologicsBiotherapeutics Advanced Therapeutics Specialty Technologies SpecialtyInhalationInhalation Development & Analytical Nasal Delivery Dry Powder Inhalers Development & Analytical Services Small Molecule Injectable Regulatory Support Services Orphan Drugs Emerging Biotech Solutions Clinical SupplyForecasting & Planning Packaging Services Comparator Sourcing Distribution & Logistics ConsumerOver-The-Counter Nutritional Supplements Beauty Product Library Expert ContentBiologics Clinical Supply Services Consumer Health Cell Therapy Gene Therapy Development & Bioavailability Dose Form Design Inhalation Oral Manufacturing Oral Technologies Small Molecule Analytical Small Molecule Injectable Softgel Technologies LocationsAsia Pacific Europe Latin America North America Site Tours Who We Are News & Events Our Leadership Our Scientists How We Create Investors Corporate Responsibility Diversity & Inclusion Careers Contact UsOral Dose Development & Bioavailability Preclinical Development Formulation Bioavailability Enhancement Integrated Development Solutions OptiForm® Solution Suite Catalent Xpress Pharmaceutics™ Dose Form Design OptiDose® Design Solution Tablets & Capsules Orally Disintegrating Tablets Softgel Technology Stick Pack Oral Technologies Bioavailability Enhancement Modified Release Formulations Orally Disintegrating Tablets Abuse Deterrent Oral Macromolecule Delivery Softgel Technologies RP Scherer Softgel Technology Plant Based Softgel Technology Oral Macromolecule Delivery Abuse Deterrent Technology Smaller Easy to Swallow Softgels Oral Manufacturing Commercial Manufacturing Scale-Up & Product Launch Technology Transfers OneXpress™ Solution Oral Dose Packaging Oral Dose Analytical Solutions Solid State Screening Methods Development & Validation Stability Testing & Storage Highly Potent Active Pharmaceutical Ingredients Biologics Biotherapeutics Advanced Therapeutics Specialty Technologies Specialty Inhalation Inhalation Development & Analytical Nasal Delivery Dry Powder Inhalers Development & Analytical Services Small Molecule Injectable Regulatory Support Services Orphan Drugs Emerging Biotech Solutions Clinical Supply Forecasting & Planning Packaging Services Comparator Sourcing Distribution & Logistics Consumer Over-The-Counter Nutritional Supplements Beauty Product Library Expert Content Biologics Clinical Supply Services Consumer Health Cell Therapy Gene Therapy Development & Bioavailability Dose Form Design Inhalation Oral Manufacturing Oral Technologies Small Molecule Analytical Small Molecule Injectable Softgel Technologies Locations Asia Pacific Europe Latin America North America Site ToursWho We Are News & Events Our Leadership Our Scientists How We Create Investors Corporate Responsibility Diversity & Inclusion Careers Regional Sites China Japan Latin America Spanish Portuguese Investor Relations Investor Relations IR Navigation Investors Catalent, Inc. (NYSE: CTLT), is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,500 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply approximately 70 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 17,800 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $4.3 billion in revenue in its 2023 fiscal year. For more information, visit www.catalent.com . Latest Financials News View all news Latest Presentation Latest Events View All Events Contact Us Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: [email protected] Quick Links SEC Filings Investor FAQs Information Request Form Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Catalent, Inc. we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Catalent, Inc. to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations Unsubscribe Email Alert Sign Up Confirmation Expert Content Subscribe Investors Careers Contact Us Site Map Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement Copyright 2022, Catalent, Inc - All Rights Reserved Terms Modern Slavery...